DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo

Celgene (NASDAQ: CELG)

113.35 3.75 (3.42%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $113.35 3.42%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $111.16
Previous Close $109.60
Daily Range $110.56 - $113.91
52-Week Range $66.85 - $119.84
Market Cap $90.5B
P/E Ratio 57.38
Dividend (Yield) $0.00 (0.0%)
Volume 4,669,869
Average Daily Volume 5,308,421
Current FY EPS $3.26





Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

3 Pharma Giants Growing Significantly Faster Than GlaxoSmithKline PLC

GlaxoSmithKline is a common retirement holding, but there are three other big pharma stocks growing significantly faster that investors could choose from.

Stock Market News for December 26, 2014 - Market News

S&P 500 Movers: EQT, GILD

Nasdaq 100 Movers: VIP, GILD

S&P 500 Movers: RIG, CELG

Nasdaq 100 Movers: VIP, CELG

Jim Cramer's Picks for What to Buy in Oil and Biotech Into 2015

Why I Expect The Biotech Sell-Off To Continue Into 2015

Biotech Stocks Are Falling: 3 Top Stocks to Buy

Gilead Sciences, Celgene Corp, and Biogen Idec may offer investors long-term opportunity.

S&P 500 Movers: CELG, CHK

See More CELG News...

CELG's Top Competitors

CELG $113.35 (3.42%)
Current stock: CELG
GILD $93.79 (2.74%)
Current stock: GILD
AMGN $163.46 (1.74%)
Current stock: AMGN
$0.00 (0.00%)
Current stock: